These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1258359)

  • 1. Preparation and immunogenicity of an influenza virus hemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Virology; 1976 Feb; 69(2):511-22. PubMed ID: 1258359
    [No Abstract]   [Full Text] [Related]  

  • 2. [Methodological bases for obtaining subunit vaccines].
    Vasil'eva GA
    Tr Inst Im Pastera; 1982; 59():129-33. PubMed ID: 7187565
    [No Abstract]   [Full Text] [Related]  

  • 3. The significance of influenza virus neuraminidase in immunity.
    Rott R; Becht H; Orlich M
    J Gen Virol; 1974 Jan; 22(1):35-41. PubMed ID: 4855928
    [No Abstract]   [Full Text] [Related]  

  • 4. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Kasel JA; Laver WG
    Dev Biol Stand; 1977 Jun 1-3; 39():243-8. PubMed ID: 604104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature-Sensitive mutants of influenza virus. VII. Transfer of the TS-1[E] lesions to a wild-type influenza A virus with the HON1 surface antigens.
    Murphy BR; Spring SB; Richman DD; Tierney EL; Kasel J; Chanock RM
    Virology; 1975 Aug; 66(2):533-41. PubMed ID: 1171556
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody responses to inactivated influenza vaccines and partial protective effect of anti-neuraminidase antibody against epidemics of A(H3N2) and A(H1N1) influenza.
    Maeda A; Oishi I; Minekawa Y; Kunita N; Funahashi S; Yagura H
    Biken J; 1979 Sep; 22(3):91-8. PubMed ID: 533537
    [No Abstract]   [Full Text] [Related]  

  • 7. A new, surface-antigen-adsorbed influenza virus vaccine. I. Studies on immunogenicity in hamsters.
    Jennings R; Potter CW; McLaren C; Brady M
    J Hyg (Lond); 1975 Dec; 75(3):341-52. PubMed ID: 1059704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on anti-neuraminidase antibody response in serum after inoculation of influenza hemagglutinin vaccines].
    Hiromatsu Y; Sato Y; Inoguchi T; Umeno H; Kurosawa Y; Ishii K; Kobayashi K; Kaji M; Shingu T; Hayashida K
    Kansenshogaku Zasshi; 1984 May; 58(5):367-75. PubMed ID: 6434660
    [No Abstract]   [Full Text] [Related]  

  • 9. [Successive isolation of hemagglutinin and neuraminidase from influenza virus A/Kransnodar/101/59 (H2N2) using bromelain].
    Arbatskiĭ NP; Zheltova AP; Iurtov DV; Derevitskaia VA; Kochetkov NK
    Dokl Akad Nauk SSSR; 1989; 306(6):1490-3. PubMed ID: 2806058
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of hemagglutinin and neuraminidase on influenza virions as revealed by immunoelectron microscopy.
    Murti KG; Webster RG
    Virology; 1986 Feb; 149(1):36-43. PubMed ID: 3511607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influenza virus neuraminidase and its role in anti-influenzal immunity].
    Isaeva EI; Platonova AL; Rovnova ZI; Kosiakov PN
    Vopr Virusol; 1979; (6):615-9. PubMed ID: 524858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective solubilization of hemagglutinin and neuraminidase from influenza viruses.
    Bachmayer H
    Intervirology; 1975; 5(5):260-72. PubMed ID: 1225862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of influenza virus neuraminidase with hemagglutinin activity and its comparison with that of viral neuraminidase.
    Arora DJ; Gabriel LF
    Biochim Biophys Acta; 1986 Oct; 884(1):73-83. PubMed ID: 3533157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and immunogenicity of a purified influenza virus haemagglutinin and neuraminidase subunit vaccine.
    Laver WG; Webster RG
    Postgrad Med J; 1976 Jun; 52(608):373-8. PubMed ID: 785428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractionation of the influenza virus with the object of producing subunit vaccine.
    Hoyle L; Barker SM
    Postgrad Med J; 1973 Mar; 49(569):193-4. PubMed ID: 4802482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody formation in laboratory animals after parenteral application of A/swine influenza virus.
    Dolezalová B; Závadová H; Stárek M; Vonka V
    Dev Biol Stand; 1977 Jun 1-3; 39():405-8. PubMed ID: 604122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents.
    Phelan MA; Mayner RE; Bucher DJ; Ennis FA
    J Biol Stand; 1980; 8(3):233-42. PubMed ID: 7410447
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical trials with a new influenza subunit vaccine in adults and children.
    Kunz C; Hofmann H; Bachmayer H; Liehl E; Moritz AJ
    Dev Biol Stand; 1977 Jun 1-3; 39():297-302. PubMed ID: 342311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to influenza.
    Schild GC; Oxford JS; Virelizier JL
    Dev Biol Stand; 1975; 28():253-72. PubMed ID: 47824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.